AU2020903780A0 - Pharmaceutical formulations - Google Patents
Pharmaceutical formulationsInfo
- Publication number
- AU2020903780A0 AU2020903780A0 AU2020903780A AU2020903780A AU2020903780A0 AU 2020903780 A0 AU2020903780 A0 AU 2020903780A0 AU 2020903780 A AU2020903780 A AU 2020903780A AU 2020903780 A AU2020903780 A AU 2020903780A AU 2020903780 A0 AU2020903780 A0 AU 2020903780A0
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180084972.1A CN116583272A (en) | 2020-10-19 | 2021-10-18 | Oral cannabinoid formulations comprising tocopherol phosphate and long chain triglycerides or long chain fatty acids |
CA3195937A CA3195937A1 (en) | 2020-10-19 | 2021-10-18 | Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids |
PCT/AU2021/051211 WO2022082256A1 (en) | 2020-10-19 | 2021-10-18 | Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids |
US18/249,632 US20230381207A1 (en) | 2020-10-19 | 2021-10-18 | Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids |
JP2023547723A JP2023546267A (en) | 2020-10-19 | 2021-10-18 | Oral cannabinoid preparations comprising tocopheryl phosphate and long chain triglycerides or long chain fatty acids |
IL302160A IL302160A (en) | 2020-10-19 | 2021-10-18 | Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids |
EP21881369.9A EP4228612A1 (en) | 2020-10-19 | 2021-10-18 | Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2020903780A0 true AU2020903780A0 (en) | 2020-11-12 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4045480A4 (en) | Pharmaceutical formulations | |
EP4149470A4 (en) | Pharmaceutical formulations and uses thereof | |
EP3946316A4 (en) | Cannabidiol pharmaceutical compositions | |
EP4028059A4 (en) | Stable medicinal cannabidiol compositions | |
EP4135699A4 (en) | Pharmaceutical compositions | |
EP4122483A4 (en) | Oral pharmaceutical composition | |
EP4015001A4 (en) | Oral pharmaceutical composition | |
EP4048276A4 (en) | Solid pharmaceutical formulations comprising ticagrelor | |
GB202010230D0 (en) | Pharmaceutical formulation | |
EP3946296A4 (en) | Extended release pharmaceutical formulation | |
EP4058025A4 (en) | Pharmaceutical compositions comprising ticagrelor | |
EP4190310A4 (en) | Stable pharmaceutical preparation | |
EP4197540A4 (en) | Drug formulation containing sepetaprost | |
EP4081251A4 (en) | Pharmaceutical compositions | |
EP3914234A4 (en) | Pharmaceutical compositions | |
EP3746080A4 (en) | Pharmaceutical formulations | |
AU2020903781A0 (en) | Pharmaceutical formulations | |
AU2020903780A0 (en) | Pharmaceutical formulations | |
TWI848533B (en) | Ribociclib pharmaceutical compositions | |
AU2023221615A1 (en) | Pharmaceutical formulation | |
EP4205765A4 (en) | Stable pharmaceutical preparation | |
TWI800878B (en) | Drug set | |
ZA202212663B (en) | Pharmaceutical formulations | |
IL308250A (en) | Pharmaceutical formulations | |
GB202112820D0 (en) | Pharmaceutical formulations |